Meetings held in the UPMC Cancer Pavilion 5 East Conference Room (Reviewers only)
Committee A – 3:30-5:00 P. M. Committee B – 2:00 - 4:00 P. M.
University of Pittsburgh Cancer Institute (UPCI) Protocol Review Committees (PRC) meeting dates and deadlines for submission for 2009 are as follows:
| COMMITTEE A Andrew Laman, MD, Chair |
COMMITTEE B Leonard Appleman, MD, Chair |
|||
| DEADLINE DATES FOR SUBMISSION |
MEETING DATES | DEADLINE DATES FOR SUBMISSION |
MEETING DATES | |
|---|---|---|---|---|
| January 2, 2009 | January 12, 2009 | January 16, 2009 | January 26, 2009* | |
| January 30, 2009 | February 9, 2009 | February 13, 2009 | February 23, 2009 | |
| February 27, 2009 | March 9, 2009 | March 13, 2009 | March 23, 2009 | |
| March 27, 2009 | April 6, 2009 | April 10, 2009 | April 20, 2009 | |
| April 24, 2009 | May 4, 2009 | May 8, 2009 | May 18, 2009 | |
| May 29, 2009 | June 8, 2009 | June 12, 2009 | June 22, 2009* | |
| July 1, 2009 | July 13, 2009 | July 17, 2009 | July 27, 2009 | |
| July 31, 2009 | August 10, 2009 | August 14, 2009 | August 24, 2009 | |
| September 2, 2009 | September 14, 2009 | September 18, 2009 | September 28, 2009 | |
| October 2, 2009 | October 12, 2009 | October 16, 2009 | October 26, 2009 | |
| October 30, 2009 | November 9, 2009 | November 13, 2009 | November 23, 2009 | |
| November 25, 2009 | December 7, 2009 | December 11, 2009 | December 21, 2009 | |
Deadlines for submission to the PRC are approximately 10 days before the scheduled meeting date. Any trials that do not have the required documentation for review will not be placed on the agenda for the meeting. Documents required are: (1) a completed PRC checklist, (2) a copy of full protocol, (3) a sponsor or UPCI consent form, and (4) investigator drug brochure. All trials must be signed-off by the Disease Center Leader and all investigator-initiated trials must be approved by the Disease Site Leader prior to submission to the PRC. Documents can be emailed to Brandon Kaukus at kaukusbm@upmc.edu; call 412-623-3376 if you have any questions.
Please note, any incomplete submissions may delay the review of your protocol to the next available meeting.